Clinical Research Groupsp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2012-10-18
Share capital
100,000.00 PLN
Registered address
Sokołowska 9/U-2, 01-142 Warszawa, Poland

Financials

Revenue history (in k)

Filing timeliness

3 of 6 financial statements were filed late (the longest delay 348 days for 2022).

  • 202527/07/2026
  • 202415/07/2025
  • 202327/06/2024
  • 202227/06/2024
  • 202105/10/2022
  • 202015/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 27%
City · Warszawa25,711 / 57,023
Top 45%
Voivodeship · Mazowieckie35,878 / 77,210
Top 46%
Country · Poland142,908 / 298,279
Top 48%

Results vs industry

Revenue
This companyUSD 327.31kMedianUSD 55.66kAverageUSD 2.70m
Net profit
This companyUSD 19.91kMedianUSD -1.27kAverageUSD -92.16k
Operating costs
This companyUSD 300.76kMedianUSD 65.85kAverageUSD 2.66m
Assets
This companyUSD 294.10kMedianUSD 133.19kAverageUSD 3.03m

Authorized Representatives

Katarzyna Anna Jarus-Dziedzicage 58 – President of the Management Board
Kamila Karolina Padlewskaage 58 – Vice President of the Management Board

Manner of representation

In the case of a one-person management board, the company is represented by one member of the management board or by a commercial proxy independently. In the case of a multi-member management board, the company is represented by two members of the management board acting jointly.

Ownership

OwnerSharesShare valueStake
500$13,506.2150%
500$13,506.2150%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2012-10-24.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

4 public aid cases recorded, with a total value of $4,713.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,034
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,009

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Change history

DateEvent
2015-03-05PKD change
2014-11-20Address change
2012-10-18Entered in the register

FAQ

Last updated: 2026-07-27